Association between adaptive immune signature and outcome in HER2-positive breast cancer treated with trastuzumab and lapatinib in the NCCTG-N9831 (Alliance) and NeoALTTO trials
- Citation:
- J Clin Oncol vol 36 (15 suppl) abst 577
- Meeting Instance:
- ASCO 2018
- Year:
- 2018
- Type:
- Abstract
- Sub type:
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 3388
- Pharmas:
- Grants:
- U10CA180821
- Corr. Author:
- Authors:
- Saranya Chumsri Daniel Serie Afshin Mashadi-Hossein Jennifer M. Kachergus Sarah Warren Gerardo Colon-Otero Ann H. Partridge Lisa A. Carey Florentine Hilbers Veerle Van Doreen Eileen Holmes Serena Di Cosimo Olena Werner Jens Bodo Huober Jose Baselga Christos Sotiriou Edith A. Perez Amylou C. Dueck Alvaro Moreno-Aspitia E Aubrey Thompson
- Networks:
- LAPS-MA036, LAPS-MN026, LAPS-NC007, LAPS-NY016, PR028
- Study
- NCCTG-N9831
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: